Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fletcher

Showing results (1431-1440 of 1,501) with videos related to

Pageof 151
Sort By:
Nature Genetics|September 22, 2014
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumorsWilliam Lee, Sewit Teckie, Thomas Wiesner, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2025
A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolutionElishama N Kanu, Ashley A Fletcher, Jiayin Bao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumorMichael C Heinrich, Christopher L Corless, George D Demetri, et al.
Nature|February 19, 2010
Multilevel and kin selection in a connected worldMichael J Wade, David S Wilson, Charles Goodnight, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorMichael C Heinrich, Christopher L Corless, George D Demetri, et al.
Gastroenterology|April 14, 2015
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1Yujiro Hayashi, Michael R Bardsley, Yoshitaka Toyomasu, et al.
The Journal of Pathology|November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumoursSubbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.
Nature Genetics|May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutationsShinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Oncotarget|February 26, 2014
Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibitionChueh-Chuan Yen, Chung-Der Hsiao, Wei-Ming Chen, et al.
Nature Biotechnology|August 10, 2023
A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infectionAngela Wahl, Wenbo Yao, Baolin Liao, et al.
Pageof 151

Showing results (1431-1440 of 1,501) with videos related to

Sort By:
Pageof 151
Nature Genetics|September 22, 2014
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumorsWilliam Lee, Sewit Teckie, Thomas Wiesner, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2025
A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolutionElishama N Kanu, Ashley A Fletcher, Jiayin Bao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumorMichael C Heinrich, Christopher L Corless, George D Demetri, et al.
Nature|February 19, 2010
Multilevel and kin selection in a connected worldMichael J Wade, David S Wilson, Charles Goodnight, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorMichael C Heinrich, Christopher L Corless, George D Demetri, et al.
Gastroenterology|April 14, 2015
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1Yujiro Hayashi, Michael R Bardsley, Yoshitaka Toyomasu, et al.
The Journal of Pathology|November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumoursSubbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.
Nature Genetics|May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutationsShinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Oncotarget|February 26, 2014
Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibitionChueh-Chuan Yen, Chung-Der Hsiao, Wei-Ming Chen, et al.
Nature Biotechnology|August 10, 2023
A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infectionAngela Wahl, Wenbo Yao, Baolin Liao, et al.
Pageof 151